InvestorsHub Logo
Followers 1
Posts 52
Boards Moderated 0
Alias Born 10/20/2014

Re: tykundegex post# 265

Saturday, 06/22/2019 11:38:46 PM

Saturday, June 22, 2019 11:38:46 PM

Post# of 1140
53 Biotech is likely just a group Dyadic has under contract for R&D, like BDI Biotech (also from Spain).

BDI Biotech has been referenced before in some Dyadic slides:

DYADIC INFORMATION 57 Ch-VLP platform Technology basis VP2 protein is a structural protein of the Infectious Bursitis virus (IBDV; Gumboro) what naturally autoassemble forming Virus Like Particles Translation Assembling process x60 VLPs VP2 protein VP2 gene (+34) 983 54 85 63 info@bdibiotech.com C/ Louis Proust, 13 47151 Boecillo (Valladolid) - Spain


53 Biologics is in the same area (Boecillo Valladolid) as BDI, so maybe there is some connection between the two. The websites look very similar.

https://www.bdibiotech.com


Also, from Dyadic's SEC filings:

Description of Business

Dyadic International, Inc. (“Dyadic”, “we”, or the “Company”) is a global biotechnology platform company based in Jupiter, Florida with operations in the United States, a satellite office in the Netherlands and research organizations performing services under contract to Dyadic in Finland and Spain. Over the past two decades, the Company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has previously licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Myceliophthora thermophila fungus, which the Company named C1. The C1 technology is a robust and versatile fungal expression system for the development and production of enzymes and other proteins.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News